Seeing Is Believing
with an average price target of $5.21. This is a potential upside of $5.21 (0%) from yesterday's end of day stock price of $0.
Progenics Pharmaceuticals's activity chart (see below) currently has 16 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 155.25 days.
Most recent stock forecast was given by CHAD MESSER from NEEDHAM on 14-Mar-2019. First documented stock forecast 30-Jul-2012.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$5.9 (143.90%)
$12
6 years 1 months 13 days ago
(14-Mar-2019)
3/9 (33.33%)
$5.58 (126.24%)
321
Buy
$11
$6.9 (168.29%)
$9
8 years 3 months 16 days ago
(11-Jan-2017)
3/3 (100%)
$2.1 (23.60%)
165
Buy
$11
$6.9 (168.29%)
$11
8 years 6 months ago
(27-Oct-2016)
2/3 (66.67%)
$5.29 (81.82%)
135
Buy
$14
$9.9 (241.46%)
$14
8 years 9 months 7 days ago
(20-Jul-2016)
0/2 (0%)
$7.86 (128.01%)
What is PGNX (Progenics Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PGNX (Progenics Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PGNX (Progenics Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PGNX (Progenics Pharmaceuticals)?
Which analyst is the currently most bullish on PGNX (Progenics Pharmaceuticals)?
Which analyst is the currently most reserved on PGNX (Progenics Pharmaceuticals)?